Akebia Therapeutics’ fair value target is held at US$4.40 per share, with the latest model keeping this figure steady versus the prior view. That lack of movement comes even as analysts debate the ...

After a phase of strong earnings supported by firm freight rates, Great Eastern Shipping is leaning on balance sheet strength ...

A once-in-a-generation demographic wave is arriving on Florida’s Gulf Coast, and the developers, operators, and general ...

Gold Spot US Dollar, Silver Spot US Dollar, Crude Oil WTI Futures, Bitcoin US Dollar. Read 's Market Analysis on ...

Chris Sharp talks up the pace of AI silicon innovation, the growth of inferencing workloads, and why boasting about datacentre megawatts misses the point ...

Imperial Oil Limited IMO is a Canadian integrated oil company which is expected to see stronger earnings growth this year as ...

This company has so many ways to win.

An Ipsos survey of U.S. adults found 63% say ads in AI search results would reduce trust. Early advertiser data offers ...

Global gas markets remain on edge amid the heightened tension in the Middle East. Two vessels carrying fuel from Qatar’s export plant appear to be attempting to transit the Strait of Hormuz, after an ...

KeyBanc lifts Intel's price target to $70 and holds Micron at $600 as AI server demand drives chip shortages and expected Q2 ...

Wells Fargo raises AppLovin (APP) price target to $560 as mobile gaming ad revenue defies seasonal trends and Q1 estimates ...